This approach was based on the cell cycle hypothesis underlying neuronal cell degeneration, as well as the role of nuclear tau protein—specifically the AT8 epitope—as a significant marker of neuronal differentiation in neuroblastoma cell lines, as previously described [14,16]. The gene discussed is MAPT; the disease is neuroblastoma.